Picibanil - CISMeF

Preferred Label : Picibanil;

NCIt related terms : OK-432;

NCIt definition : A lyophilized formulation containing cultures of a low-virulent strain of Streptococcus pyogenes, treated and killed with penicillin G, with potential sclerosing, immunostimulating and antineoplastic activity. Besides from picibanil's direct damaging effect as a sclerosing agent, it seems to have multiple effects on the immune system as a non-specific immunostimulant. Picibanil activates the host immune system by stimulating the activity of natural killer cells, macrophages and lymphocytes, and by enhancing the production of several key immune mediators, including interleukins and tumor necrosis factor.;

UNII : 2F42BH7X2L;

CAS number : 39325-01-4;

Drug name : Picibanil;

Molecule name : OK-432;

Codes from synonyms : NSC0402815; 01775;

Details

Origin ID

C745;

UMLS CUI

C0031875;

Automatic exact mappings (from CISMeF team)
- Picibanil [SMS substance]
Currated CISMeF NLP mapping
- picibanil [MeSH Descriptor]
- picibanil [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- picibanil [MeSH Descriptor]
- picibanil [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients